Clinical Trial: Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07172360) titled 'Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.' on Sept. 08.

Brief Summary: This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Active Ankylosing Spondylitis

Intervention: DRUG: VC005 tablets

VC005 groups repeat administration for 48 weeks

DRUG: VC005 Tablets Placebo

VC005 placebo groups repeat administration for 48 weeks

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Published by HT Digital Conten...